Authors:
Strasser, JE
Arnold, RL
Pachuk, C
Higgins, TJ
Bernstein, DI
Citation: Je. Strasser et al., Herpes simplex virus DNA vaccine efficacy: Effect of glycoprotein D plasmid constructs, J INFEC DIS, 182(5), 2000, pp. 1304-1310
Authors:
Higgins, TJ
Herold, KM
Arnold, RL
McElhiney, SP
Shroff, KE
Pachuk, CJ
Citation: Tj. Higgins et al., Plasmid DNA-expressed secreted and nonsecreted forms of herpes simplex virus glycoprotein D2 induce different types of immune responses, J INFEC DIS, 182(5), 2000, pp. 1311-1320
Authors:
Bernstein, DI
Tepe, ER
Mester, JC
Arnold, RL
Stanberry, LR
Higgins, T
Citation: Di. Bernstein et al., Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection, VACCINE, 17(15-16), 1999, pp. 1964-1969
Authors:
Sin, JI
Kim, JJ
Arnold, RL
Shroff, KE
McCallus, D
Pachuk, C
McElhiney, SP
Wolf, MW
Pompa-de Bruin, SJ
Higgins, TJ
Ciccarelli, RB
Weiner, DB
Citation: Ji. Sin et al., IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4(+) T cell-mediated protective immunity against herpes simplex virus-2 challenge. (vol 162, pg 2912, 1999), J IMMUNOL, 163(2), 1999, pp. 1094-1094
Authors:
Sin, JI
Kim, JJ
Arnold, RL
Shroff, KE
McCallus, D
Pachuk, C
McElhiney, SP
Wolf, MW
Pompa-de Bruin, SJ
Higgins, TJ
Ciccarelli, RB
Weiner, DB
Citation: Ji. Sin et al., IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4(+) T cell-mediated protective immunity against herpes simplex virus-2 challenge, J IMMUNOL, 162(5), 1999, pp. 2912-2921